StockWatch
·

Sonoma Pharmaceuticals, Inc. Q2 FY26 Results

SNOAQ2 FY26 Results
MetricValue ($ M)Q1 FY26Q2 FY25
Revenue5.6039.3%56.4%
Total Income5.6039.3%56.4%
Expenditure5.9416.2%34.1%
PBT-0.7341.1%58.7%
Net Profit-0.5357.3%13.1%
OPM-6.01%21.26pp17.74pp
NPM-9.53%21.38pp7.52pp
EPS-0.3257.9%45.8%
View full financials

Informational and educational content only. Not investment advice.